This Article
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ALBRIGHT, J. A.
Right arrow Articles by GRUNT, J. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by ALBRIGHT, J. A.
Right arrow Articles by GRUNT, J. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?
Journal of Bone and Joint Surgery, 1971;53:1415-1425.
© 1971 by The Journal of Bone and Joint Surgery, Inc


Studies of Patients with Osteogenesis Imperfecta

JAMES A. ALBRIGHT M.D.1 and JEROME A. GRUNT M.D.1

1 From the Yale University School of Medicine, Departments of Orthopaedic Surgery and Pediatrics, The Newington Children's Hospital, Newington, Connecticut, and the Yale-New Haven Hospital, New Haven

Twenty children and five adults with osteogenesis imperfecta were studied for one year or more, and thirteen of the patients were treated with sodium fluoride (0.25 to 0.90 milligrams fluoride per kilogram of body weight per day). No significant abnormality of calcium, phosphorus, nitrogen, magnesium, or potassium balance, serum chemistries, urinary amino acid excretion, or calcium dynamics was detected before treatment, nor were changes seen during treatment. The over-all results do not warrant the general use of fluoride for the treatment of osteogenesis imperfecta but do warrant further study, especially of the dose-related effect.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
NEJMHome page
F. H. Glorieux, N. J. Bishop, H. Plotkin, G. Chabot, G. Lanoue, and R. Travers
Cyclic Administration of Pamidronate in Children with Severe Osteogenesis Imperfecta
N. Engl. J. Med., October 1, 1998; 339(14): 947 - 952.
[Abstract] [Full Text] [PDF]